Crespo, J.; RodrÃguez-Duque, J.C.; Iruzubieta, P.; Morel Cerda, E.C.; Velarde-Ruiz Velasco, J.A.
GLP-1 Receptor Agonists and Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus. J. Clin. Med. 2025, 14, 5597.
https://doi.org/10.3390/jcm14155597
AMA Style
Crespo J, RodrÃguez-Duque JC, Iruzubieta P, Morel Cerda EC, Velarde-Ruiz Velasco JA.
GLP-1 Receptor Agonists and Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus. Journal of Clinical Medicine. 2025; 14(15):5597.
https://doi.org/10.3390/jcm14155597
Chicago/Turabian Style
Crespo, Javier, Juan Carlos RodrÃguez-Duque, Paula Iruzubieta, Eliana C. Morel Cerda, and Jose Antonio Velarde-Ruiz Velasco.
2025. "GLP-1 Receptor Agonists and Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus" Journal of Clinical Medicine 14, no. 15: 5597.
https://doi.org/10.3390/jcm14155597
APA Style
Crespo, J., RodrÃguez-Duque, J. C., Iruzubieta, P., Morel Cerda, E. C., & Velarde-Ruiz Velasco, J. A.
(2025). GLP-1 Receptor Agonists and Gastrointestinal Endoscopy: A Narrative Review of Risks, Management Strategies, and the Need for Clinical Consensus. Journal of Clinical Medicine, 14(15), 5597.
https://doi.org/10.3390/jcm14155597